| 000 | 01219 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517130346.0 | ||
| 264 | 0 | _c20170518 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1747-4094 | ||
| 024 | 7 |
_a10.1080/17474086.2017.1270202 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPierce, John Matthew R | |
| 245 | 0 | 0 |
_aDiagnostic, prognostic and therapeutic role of CD30 in lymphoma. _h[electronic resource] |
| 260 |
_bExpert review of hematology _cJan 2017 |
||
| 300 |
_a29-37 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBrentuximab Vedotin |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoconjugates _xtherapeutic use |
| 650 | 0 | 4 |
_aKi-1 Antigen _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLymphoma _xdiagnosis |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMehta, Amitkumar | |
| 773 | 0 |
_tExpert review of hematology _gvol. 10 _gno. 1 _gp. 29-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/17474086.2017.1270202 _zAvailable from publisher's website |
| 999 |
_c26674609 _d26674609 |
||